Abstract. We investigate the evolution of tumor growth relying on a nonlinear model of partial differential equations which incorporates mechanical laws for tissue compression combined with rules for nutrients availability and drug application. Rigorous analysis and simulations are presented which show the role of nutrient and drug application in the progression of tumors. We construct an explicit convergent numerical scheme to approximate solutions of the nonlinear system of partial differential equations. Extensive numerical tests show that solutions exhibit a necrotic core when the nutrient level falls below a critical level in accordance with medical observations. The same numerical experiment is performed in the case of drug application for the purpose of comparison. Depending on the balance between nutrient and drug both shrinkage and growth of tumors can occur. The role of inhomogeneous boundary conditions, vascularization and anisotropies in the development of tumor shape irregularities are discussed.
1. Introduction 1.1. Motivation. Tumor cells can show distinct morphological and phenotypic profiles, including cellular morphology, gene expression, metabolism, motility, proliferation, and metastatic potential. The heterogeneity of cancer cells introduces significant challenges in designing effective treatment strategies. Scientific research aiming at understanding and characterizing heterogeneity can allow for a better understanding of the causes and progression of disease. In turn, this has the potential to guide the creation of more refined treatment strategies that incorporate knowledge of heterogeneity to yield higher efficacy. In recent years, the investigation of the effect of drug application in cancer progression has been the subject of intense scientific effort. Both vascularization and anisotropies affect the evolution of tumors, the shape of the surface of the tumor regime and the development of irregularities. Mathematical modeling, the construction of explicit examples and the use of simulations can establish critical conditions for the growth or the shrinkage of tumors, the development of irregularities for different types of cancers enhancing our understanding of tumor developement and heterogeneity.
Governing equations.
Over the past years research activity on the mathematical modeling and simulations on tumor growth models has increased dramatically. A variety of modeling strategies have been developed, each focusing on one or more aspects of cancer for medical prediction. Among the variety of models now available one needs to mention as a starting point the class, introduced by Greenspan [9] , which considers that cancerous cells multiplication is due to nutrients (glucosis, oxygen) brought by blood vessels. The first stage, where growth is limited by nutrients, lasts until the tumor reaches a certain size; subsequently, lack of food leads to cell necrosis which triggers neovasculatures development that supply the tumor with enough nourishment. This process has motivated a new generation of models where growth is effected both by the nutrient supply and the competition for space, enriching the modeling effort with mechanical considerations, viewing tissues as multiphase fluids. This is the point of view adopted in our investigation.
1.2.1. Transport equations for the evolution of the cell densities. All the cells are assumed to follow the general continuity equation:
∂ t n − div(nu) = nΦ(p, c, q), x ∈ Ω, t ≥ 0 (1.1)
where n represents the number density of tumor cells, u the velocity field, c is the concentration of the nutrient (oxygen) and q the density of the drug. In the present context, p denotes the pressure of the tumor and Ω a bounded domain in
The function Φ accounts for the effect of pressure, nutrient and drug to the evolution of cancerous cells and has the general form Φ(p, c, q) = g 1 (c, q)G(p) − g 2 (c, q), (1.2) where g i , i = 1, 2 are bounded and nonnegative. For G we assume that it is of the form
where P M is the so called homeostatic pressure, the critical threshold at which the cell division is stopped by contact inhibition. It is related to the compression a cell can experience [3] . The factor g 1 (c, q) is nondecreasing in c and nonincreasing in q and accounts for the growth/decline of the cell culture in relation to the nutrient and drug concentration. The term g 2 (c, q) accounts for the decrease of the cell density when the nutrient concentration falls below a critical level to sustain cell life (cells starve) and also models the effect of the drug application on the tumor growth. It can for example be of the form g 2 (c, q) = g 2,1 (c) + g 2,2 (q). The pressure law is given by 4) where γ ≥ 2. Here, and in what follows, for simplicity we let
for some α, β > 0, where g 0 (p) = g 0 (n) is such that ng 0 (n) is nondecreasing. This includes for example functions of the form g 0 (p) = p θ for θ > 0.
1.2.2.
The tumor tissue as a porous medium. The continuous motion of cells within the tumor region typically due to proliferation is represented by the velocity field u := ∇W given by an alternative to Darcy's equation known as Brinkman's equation
where µ is a positive constant describing the viscous like properties of tumor cells and p is the pressure given by (1.4) . Relation (1.6) extents the usual Darcy's law, by taking into account the dissipative force density, which results from the internal cell friction due to cell volume changes.
1.2.3.
A linear diffusion equation for the evolution of nutrient. Tumor cells consume nutrients (oxygen). In contrast to the equations of cell densities, the equations of the oxygen molecules in the tumor include diffusion terms in the following form:
∂ t c − ∇ · (ν c ∇c) = cΨ c (n, c) + r c (c supp − c).
Assuming that ν c is constant this equation (cf. Friedman [8] ), the equation becomes
The function Ψ c is nonpositive and accounts for the consumption of the nutrient by the cell culture. According to (cf. Ward and King [18, 17] ) the nutrient is consumed at a rate proportional to the rate of cell mitosis, which is accounted by the first term on the right-hand side. r c > 0 is the rate at which the nutrient is supplied to the tumor region (term with c supp ) and the consumption by he healthy cells (term with c).
1.2.4.
A linear diffusion equation for the evolution of drug. The evolution of the drug concentration in the tumor is given by a diffusion equation of the form
Assuming that ν q is constant this equation becomes
with Ψ q (·) a smooth nonpositive function. This equation describes the diffusion of the drug within the tumor region. The first term of the right-hand side of (1.8) represents the drug consumption and can be viewed as a measure of the drug effectiveness. The second term on the right represent the rate by which the drug is applied to the tumor region. The resulting model, governed by the transport equation (1.1) for the population density of cells, the elliptic equation (1.6) for the velocity field and a state equation for the pressure law (1.4), now reads
We complete the system (1.9) with a family of initial data n 0 satisfying (for some constant C)
(1.10)
for some constants 0 ≤ c ∞ , q ∞ < ∞.
The objective of this work is to design an efficient numerical scheme for the approximation of the solution to the nonlinear system (1.9) and to establish that this scheme converges when the mesh is refined; yielding at the same time the global existence of weak solutions to the nonlinear model for tumor growth (1.9). The main ingredients of our approach and contribution to the existing theory on Hele-Shaw-type systems for tumor growth include:
• The design of an efficient numerical scheme for the numerical approximation of the nonlinear system (1.9a)-(1.9d) with the aid of a finite difference scheme.
• The proof of the convergence of the numerical scheme, which is achieved by establishing the strong convergence of the cell densities. This property is obtained as a consequence of the weak continuity of the effective viscous pressure (cf. Section 4).
• The construction of numerical experiments that establish various cancer phenomena confirmed by clinical observations providing criteria for the development of certain types of tumor heterogeneities.
For relevant results on the analysis and the numerical approximation of a twophase flow model in porous media we refer the reader to [5] . Related work on the mathematical analysis of mechanical models of Hele-Shaw-type have been presented by Perthame et al. [14, 15] . In [16] , Trivisa and Weber presented a convergent explicit finite difference scheme for the numerical approximation of a Hele-Shawtype system for the evolution of cancerous cells and presents numerical observations in two space dimensions. The work [16] is according to our knowledge the first article that presents rigorous analytical results on the global existence of general weak solutions to Hele-Shaw-type systems. The present article extends the analysis in [16] significantly by investigating the delicate interplay of nutrient and drug application in the treatment of cancer. We refer the reader to [7, 8, 4] where a class of relevant tumor growth models with nutrient and drug application are presented and to the manuscript [1] which provides an overview of mathematical methods and tools for modeling cancer phenomena.
1.3.
Outline. The paper is organized as follows: Section 1 presents the motivation, modeling and introduces the necessary preliminary material. Section 2 provides a weak formulation of the problem and states the main results. Section 3 is devoted to the global existence of solutions via a vanishing viscosity approximation. In Section 4 we present an efficient finite difference scheme for the approximation of the weak solution to system (1.9) on rectangular domains and prove its convergence. We conclude by presenting extensive numerical tests in Section 5.
Weak formulation and main results
We start by defining a notion of a weak solution to system (1.9):
with smooth boundary ∂Ω and T > 0 a finite time horizon. We say that (n, W, p, c, q) is a weak solution of problem (1.1)-(1.6) supplemented with initial data (n 0 , W 0 , p 0 , c 0 , q 0 ) satisfying (1.10) provided that the following hold:
We remark that in the weak formulation, it is convenient that the equations (1.1) hold on the whole space R d provided that the densities n are extended to be zero outside the tumor domain.
• Brinkman's equation (1.6) 
The main result of the article now follows.
Theorem 2.2.
Let Ω ⊂ R d be a bounded domain with smooth boundary ∂Ω, 0 < T < ∞. Assume that the initial data n 0 ∈ L ∞ (Ω) with 0 ≤ n 0 ≤ n ∞ := P 1/γ M and that Φ(·) is of the form (1.2), (1.3) and (1.5). Then the problem (1.1)-(1.6) admits a weak solution in the sense specified in Definition 2.1.
In Section 3, we will obtain such a solution as the limit of a vanishing viscosity approximation (n ε , W ε , p ε , c ε , q ε ) of (3.1) to (1.9) as ε → 0 on a domain with smooth boundary ∂Ω and in Section 4 as the limit of the sequence of approximations (n h , W h , p h , c h , q h ) computed by the numerical scheme (4.1) -(4.3) as h → 0 on a rectangular domain Ω.
Global existence via vanishing viscosity
In this section we prove Theorem 2.2 by constructing an approximating scheme which relies on the addition of artificial viscosity in the cell density evolution equation In addition, we assume that for constants 0 < c ∞ , q ∞ < ∞,
Theorem 3.1. For every ε > 0, the parabolic-elliptic system (3.1) admits a unique smooth solution (n ε , W ε , p ε , c ε , q ε ).
Proof. The proof of this result relies on classical arguments (cf. Ladyzhenskaya [10] ). For details we refer the reader to Lunardi [12, Theorem 5.1.2] in the context of a related parabolic partial differential equation.
The remaining part of this section aims to establish the necessary compactness of the approximate sequence of solutions (n ε , W ε , p ε , c ε , q ε ).
3.1. A priori estimates. We start by proving that n ε are uniformly bounded independent of ε > 0 and nonnegative: Lemma 3.2. For any t > 0, the functions n ε (t, ·) are uniformly (in ε > 0) bounded and
Proof. The proof of this lemma is similar to the proof of Lemma 3.2 in [16] . All that needs to be done is replacing the function G on the right hand side of the equation by Φ and checking that it satisfies the right growth conditions.
As a next step, we prove positivity and uniform boundedness of the nutrient sequence {c ε } ε≥0 .
Lemma 3.3. For any t > 0, the functions c ε (t, ·) are uniformly (in ε > 0) bounded and
Proof. For the ease of notation, we omit writing the subscript ε. To prove the nonnegativity, let us assume that (t 0 , x 0 ) is a point where c(t 0 , x 0 ) = 0 for the first time (i.e. c(t, x) > 0 for any 0 ≤ t < t 0 and any x ∈ Ω). Then c(t 0 , x) ≥ 0 for all x in some small neigborhood of x 0 and hence ∆c(t 0 , x 0 ) ≥ 0. Thus, bringing the Laplace term to the right hand side of equation (3.1c), we have
where we used that by assumption c(t 0 , x 0 ) = 0 for the second equality and that ∆c(t 0 , x 0 ) ≥ 0 for the inequality. Thus at a point where c becomes zero, the time derivative of c is positive and it will thus stay nonnegative. To show the uniform boundedness, let us denote c := c ∞ − c. Then, c satisfies the equation
We show that c remains nonnegative (it is initially nonnegative by the assumptions on the initial data c 0 and on the boundary by assumptions on c b ). We therefore again assume that (t 0 , x 0 ) is a point where c(t 0 , x 0 ) = 0 for the first time (i.e. c(t, x) > 0 for any 0 ≤ t < t 0 and any x ∈ Ω). Then c(t 0 , x) ≥ 0 for all x in some small neigborhood of x 0 and hence ∆ c(t 0 , x 0 ) ≥ 0. We use this fact and that c(t 0 , x 0 ) = 0 in the evolution equation for c:
By the assumptions on Ψ c , Ψ c (n, c ∞ ) ≤ 0, and hence the right hand side is nonnegative. Therefore, c remains nonnegative which implies the boundedness of c.
Positivity and uniform boundedness of the sequence of the drug functions {q ε } ε≥0 is proved in the same way. Next, we prove a regularity estimate for the nutrient c ε .
Lemma 3.4. We have that, uniformly for all ε > 0,
In particular,
where C is a constant independent of ε > 0.
Proof. For the ease of notation, we omit writing the subscript ε of c ε . Let us define the function c := c− c b , where c b is the smooth extension of c b to the whole domain. It satisfies the equation
Now we multiply the evolution equation for c by c and integrate over the spatial domain. After integration by parts and using the homogeneous Dirichlet boundary conditions for the boundary integral contributions, we obtain, 1 2
Thanks to the L ∞ -bounds on n ε and c ε from Lemmas 3.2 and 3.3 and the smoothness of c b , we obtain that the right hand side is bounded. Thus integrating in time, we obtain that c ∈ L 2 ([0, T ]; H 1 (Ω)). Since c differs from c only by the smooth function c b , we obtain that the same holds for c. The L 2 ([0, T ]; H −1 (Ω))-bound on ∂ t c then follows using this, from the equation it satisfies.
Remark 3.5. It is possible to obtain higher order interior regularity estimates for
However, we will not need this for the proof of convergence of the approximating sequence and therefore omit the proof of this fact here.
Remark 3.6. Using exactly the same arguments, it is shown that
Next we recall Lemma 3.3 from [16] which gives us higher order regularity estimates for W ε .
Lemma 3.7. We have that
for any q ∈ [1, ∞), all compact subsets Ω ⊂⊂ Ω, uniformly in ε > 0 and
uniformly in ε > 0 as well.
Proof. This lemma was proved as Lemma 3.3 in [16] .
3.2. Entropy inequalities for n ε . To prove strong convergence of the approximating sequence {(n ε , W ε , p ε , c ε , q ε )} ε>0 , it is useful to derive entropy inequalities for n ε . To this end, we recall the following lemma:
Lemma 3.8. Let f : R → R be a smooth convex function and denote f ε := f (n ε ). Then f ε satisfies the following identity
where
3)
with C > 0 a constant independent of ε > 0. In particular, this implies that
Proof. The identity (3.2) follows by multiplying the evolution equation for n ε , (3.1a), by f (n ε ), applying chain rule, integrating the inequality in space and time, and following similar line of argument as in [16, Lemma 3.4 
]).
Remark 3.9. The preceeding lemma implies that the time derivative of the approximation of the pressure
3.3. Passing to the limit ε → 0. The estimates of the previous (sub)sections allow us to pass to the limit ε → 0 in a subsequence still denoted ε and conclude existence of limit functions
Using Aubin-Lions' lemma for W ε , c ε , q ε and ∇W ε , we obtain strong convergence of a subsequence in
Moreover, from the estimates in Lemma 3.7 we obtain that
where nΦ(p, c, q) is the weak limit of n ε Φ(p ε , c ε , q ε ). To conclude that the limit (n, W, p, c, q) is a weak solution of (1.9), we need to show that n ε converges strongly and therefore in the limit p = p := n γ and nΦ(p, c, q) = nΦ(p, c, q), Ψ c (n, c) = Ψ c (n, c) and Ψ q (n, q) = Ψ q (n, q). For this purpose, we combine a compensated compactness property (Lemma 3.11) with a monotonicity argument. We will also make use of the following lemma which was proved in a more general form in [6, 13] and which we proved in this particular form in [16, Lemma 3.6]:
in the sense of distributions. Then they satisfy for all continuously differentiable functions b ∈ C 1 (R)
in the sense of distribution.
Proof. The proof of this Lemma can be found in the appendix.
Applying Lemma 3.10 for the weak limit n in (3.4) with b(n) = n 2 , we obtain that n satisfies
for any test functions ϕ ∈ C 1 0 ((0, T ) × Ω). Besides that, we obtain from integrating (3.2) for f (n) = n 2 in space and time
Passing to the limit ε → 0 in this inequality, we have
where n 2 denotes the weak limit of n 2 ε and n 2 ∆W and n 2 Φ(p, c, q) are the weak limits of n 2 ε ∆W ε and n 2 ε Φ(p ε , c ε , q ε ) respectively. Letting τ → 0 in this inequality, we obtain, thanks to the boundedness of the integrand on the right hand side,
Therefore, since b(n) = n 2 is convex, n 2 ≥ n 2 and so n 2 (0, x) = n 2 0 (x). We now choose smooth test functions ϕ approximating ϕ(t, x) = 1 [0,τ ] (t), where τ ∈ (0, T ], in inequality (3.7) and then pass to the limit in the approximation to obtain the inequality
Subtracting (3.9) from (3.8), we have
(3.10)
Now using the explicit expression of Φ, (1.2), the first term on the right hand side can be estimated as follows:
The second inequality follows from the strong convergence of {c ε } ε>0 and {q ε } ε>0 , the first inequality from the nonnegativity of g 2 and the convexity of b(n) = n 2 , for the second last inequality, we used [13, Lemma 3.35] and for the last inequality the boundedness of g 1 . To estimate the second term on the right hand side of (3.10), we use that ∆W is bounded thanks to Lemma 3.7 and that n 2 ≥ n 2 by the convexity of f (x) = x 2 . Hence
In order to deal with the last term, we use the following lemma from (cf. Lemma 3.7, Trivisa and Weber [16] ). We present here the main steps of the proof for completeness.
Lemma 3.11. The weak limits (n, W, p) of the sequences {(n ε , W ε , p ε )} ε>0 satisfy for smooth functions S : R → R,
where S(n)∆W , S(n), pS(n) are the weak limits of S(n ε )∆W ε , S(n ε ) and p ε S(n ε ) respectively.
Proof. We multiply the equation for W ε by S(n ε ) and integrate over Ω,
Passing to the limit ε → 0, we obtain
On the other hand, using the smooth function S(n ε ) as a test function in the weak formulation of the limit equation
and passing to the limit ε → 0, we obtain
Combining the last identity with (3.14), we obtain (3.13).
Applying this lemma to the second term in (3.10) with S(n) = n 2 , we can estimate it by
using that n γ n 2 ≤ n 2+γ (cf. [13] ). Thus,
Hence Grönwall's inequality implies Ω n 2 − n 2 (τ )dx ≤ 0. By convexity of the function b(n) = n 2 we have n 2 ≤ n 2 almost everywhere and hence n 2 (t, x) = n 2 (t, x) almost everywhere in (0, T ) × Ω. Therefore we conclude that the functions n ε converge strongly to n almost everywhere and in particular also p = n γ which means that the limit (n, W, p, c, q) is a weak solution of the equations (1.9).
Global existence via a numerical approximation
In this section, we will construct a finite difference scheme to approximate (1.9) on a rectangular domain, for simplicity we will use Ω = [0, 1] d where d = 1, 2, 3 is the spatial dimension; the extension of the scheme to other rectangular domains with nonuniform mesh widths is straighforward. The assumptions on initial and boundary data are the same as in Section 3. We denote N x ∈ N the number of grid cells in one coordinate direction, h := 1/N x the mesh width and N t = N x /κ ∈ N the number of time steps and ∆t := 1/N t the time step size. We will determine conditions on the time step size ∆t = κh > 0 later on. We define gridpoints and grid cells
and time steps t m := m∆t, m = 0, . . . , N t . To simplify notation, we introduce the multiindex i ∈ I Nx := {0, . . . , N x } d , such that i = (i 1 , . . . , i d ) and we can write
We will approximate (n, W, p, c, q) at these points. Specifically,
. where f ∈ {n, W, p, c, q}. Next, we let e 1 := (1, 0, 0), e 2 := (0, 1, 0), and e 3 := (0, 0, 1). Using these vectors, we then define the forward and backward difference operators
respectively, for j = 1, . . . , d, and i ∈ I Nx . Based on these, we define the discrete Laplace, divergence and gradient operators,
Whenever the choice of the forward ∇ where the flux
The diffusion equations (1.9c) and (1.9d) naturally require a quadratic CFL-condition whereas the transport equation only requires a linear one. We therefore use operator splitting to solve the whole system, specifically, we evolve n 
and analoguously we approximate c 0 and q 0 .
Remark 4.1 (Implicit time stepping). Another option would be to compute the solutions to the diffusion equations (1.9c) and (1.9d) implicitely, that would improve the CFL-condition, however becomes expensive in several space dimension because matrices corresponding to the difference operators have to be inverted in every timestep.
Estimates on approximations.
In the following, we will prove estimates on the discrete quantities (n 
where f ∈ {n, W, p}. For the nutrient c and the drug q we define
We first prove that n h stays nonnegative and uniformly bounded from above. 
we have for all m ≥ 0,
Proof. The proof goes by induction on the timestep m. Clearly, by the assumptions, we have 0 ≤ n 0 i ≤ n ∞ . For the induction step we therefore assume that this holds for timestep m ≥ 0 and show that it implies the nonnegativity and boundedness at timestep m + 1.
We first show that the W 
, N x } for some j ∈ {1, . . . , d}, then because of the Neumann boundary conditions, the forward/backward difference in direction of the boundary is zero and thus the previous inequality is true as well). Hence
Similarly, at a local minimum W 
We note that β m,± i,j ≥ 0, and that under the CFL-condition (4.5), also α We proceed to showing the boundedness of n h . Thanks to the CFL-condition (4.5), we have
Furthermore, α 
We can rewrite and bound α 
where we have used (4.7) for the first inequality, that
, with f (a) = a γ , for the second inequality and the CFL-condition for the last inequality. Now going back to (4.9) and inserting this there, we obtain, 
where we used the definition of n ∞ for the last equality. This proves that n m+1 i ≤ n ∞ for all i if the same holds already for the n m i . Remark 4.3. The estimates in the proof of the previous lemma are quite coarse and balancing the terms in a more carefu way one ends up with a better CFL-condition than (4.5) in practice. Also note that n ∞ → n ∞ when ∆t → 0.
Next we prove that the approximations {c h } h>0 of the nutrient function are nonnegative and uniformly bounded. A similar argument can be used to show that the sequence of approximations {q h } h>0 is nonnegative and uniformly bounded.
where ∆t > 0 satisfies (4.5), and To prove the uniform boundedness, we proceed in a very similar way. We define c We observe that this is in fact (4.12) -(4.13) with α
In analogy to the continuous case, we would like to prove estimates on higher order differences of c h to conclude strong convergence of the sequence {c h } h>0 .
Lemma 4.5. Let ∆t c satisfy the CFL-condition (4.11), ∆t satisfy (4.5) and 0 ≤ c 
where we have used that c s i satisfy homogeneous Dirichlet boundary conditions. We note that
and estimate the second term,
where C is a constant not depending oh h and ∆t c , by the CFL-condition (4.11). Therefore, multiplying by ∆t c h d and summing over all s, we obtain, using N c ∆t c = ∆t,
Using induction on m in the last estimate and that c h differs from c h by a bounded function with bounded first differences, we obtain that
Remark 4.6. Maximum principles, nonnegativity of q h and estimates on ∇ h q h are proved in exactly the same way.
4.2.1.
Estimates on the discrete potential W h . Lemma 4.7. We have that
uniformly in h > 0, where
uniformly in h > 0 as well.
Proof. The proof of this lemma can be found in [16, Lemma 4.3].
4.3.
Discrete entropy inequalities for n h . To prove strong convergence of the approximating sequence {(n h , W h , c h , q h )} h>0 , it will be useful to derive entropy inequalities for n h . To this end, the following lemma will be useful: In particular, this implies that the piecewise constant interpolation
Proof. This lemma is a slightly more general version of Lemma 4.5 in [16] , but the proof is done in the exact same way. For details, check out [16, Lemma 4.5] .
Remark 4.9. The preceeding lemma implies that the forward time difference of the approximation of the pressure D
4.4. Passing to the limit h → 0. The estimates of the previous (sub)sections allow us to pass to the limit h → 0 in a subsequence still denoted h and conclude existence of limit functions 
Hence we have that (n, W, p, c, q) satisfy (3.4) for any test functions ϕ, ψ j ∈ C 1 ([0, T ] × Ω), j = 1, 2, 3. To conclude that the limit (n, W, p, c, q) is a weak solution of (1.9), we proceed as in the previous Section 3 and show that n h in fact converges strongly. To do so, we use the discrete entropy inequality from Lemma 4.8 and Lemma 3.10, to obtain inequalities (3.9) and (3.8). Subtracting them from each other, we get (3.10). The terms on the right hand side of the resulting expression can then be estimated in the same way as in the continuous setting in Section 3.3, after noting that a discrete version of Lemma 3.11 holds (cf. [16, Lemma 4.8] ). We conclude that the approximations of the cell density n h converge strongly to n and that the limit is in fact a weak solution of (1.9).
Numerical examples
In this section, we test the scheme from Section 4 on several different initial data and parameters. 
5.2.
With drug application. Now we consider the same example but with the addition of a drug q. We set an initial drug concentration q 0 (x) ≡ 1 constant over the domain and assume that the supply is constant over time (q b (t) ≡ q supp ≡ 1). We use Ψ q (n, q) = −15nq in the diffusion equation for the drug q. For g 2 , we use g 2 (c, q) = 8(c crit − c)1 c<ccrit + 4(q − q crit )1 q>qcrit for q crit = 0, the other functions remain as in the previous examples. The results are displayed in Figures 3, 4 , 5. The numerical experiments establish that due to the drug application the initial growth of the tumor is not as rapid as in the previous example. Moreover, the cell density does not decrease as rapidly at the center of the tumor, as a result the size of the necrotic core is smaller in this case. We observe that, depending on the balance between nutrient and drug application, both shrinkage and growth of tumors occur. The simulation results are displayed in Figures 6 (cell density) and 7 (nutrient concentration). We notice that, as time evolves, the tumor looses its spherically symmetric surface and develops irregularities in shape. It appears that the shape of the domain Ω and thereby the different levels of nutrient concentration and gradients influence this behavior. Related observations were made in [1] .
T =0 
5.4.
Inhomogeneous boundary conditions. In the last experiment, we observed that the shape of the domain and so the nutrient supply from the boundary has an effect on the shape the tumor develops. To investigate this phenomenon in Indeed, the inhomogeneous supply of nutrient affects the developing shape the tumor significantly. Figure 9 present the approximation of the nutrient in the case of initial data (5.2) and (5.3) respectively. The example shows that in the case of inhomogeneous boundary condition the model exhibits faster decay of the concentration of the nutrient in the center of the tumor. where r δ := div((nu) * ψ δ ) − div(n δ u). By [11, Lemma 2.3], we have that r δ → 0 in L 2 loc ((0, T ) × Ω) and thanks to the properties of the convolution that b(n δ ) → b(n) almost everywhere as well as f δ → f a.e. when δ → 0. Thus we obtain that in the limit δ → 0, n satisfies for some ∞ > q > 1, uniformly with respect to h > 0 and
where A h is a first order linear finite difference operator, and f h , g h , k h : Ω → R d×k are piecewise constant functions, satisfying uniformly in h > 0,
for some ∞ > r 1 , r 2 > 1.
Proof. The proof can be found in [16, Lemma A.1] .
